rhein has been researched along with Experimental Hepatoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, Y; Gao, M; Jiang, C; Jin, Q; Ni, Y; Wu, T; Yin, Z; Zhang, D; Zhang, J; Zhang, L | 1 |
| Lin, YJ; Shang, BY; Zhen, YS; Zhen, YZ | 1 |
2 other study(ies) available for rhein and Experimental Hepatoma
| Article | Year |
|---|---|
Design and Evaluation of Rhein-Based MRI Contrast Agents for Visualization of Tumor Necrosis Induced by Combretastatin A-4 Disodium Phosphate.
Topics: Animals; Anthraquinones; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Contrast Media; Disease Models, Animal; Drug Design; Humans; Liver Neoplasms, Experimental; Magnetic Resonance Imaging; Male; Mice; Mice, Nude; Necrosis; Rats; Rats, Sprague-Dawley; Stilbenes; Tissue Distribution | 2021 |
Rhein lysinate suppresses the growth of tumor cells and increases the anti-tumor activity of Taxol in mice.
Topics: Animals; Anthraquinones; Antineoplastic Agents, Phytogenic; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Female; Humans; Inhibitory Concentration 50; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Mitogen-Activated Protein Kinases; Paclitaxel; Phytotherapy; Proto-Oncogene Proteins c-akt; Rheum; Treatment Outcome | 2009 |